Avicanna Inc. ( AVCN.TO) - Stock Earnings
AVCN.TO Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q1 | 74721 CAD | 6.3 million CAD |
| 2025Q2 | -701178 CAD | 6.2 million CAD |
| 2025Q3 | -1.4 million CAD | 6.4 million CAD |
| 2026Q2 Est. | — | — |
AVCN.TO Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2022 | -14.7 million CAD | 4.0 million CAD |
| 2023 | -8.7 million CAD | 16.8 million CAD |
| 2024 | -3.6 million CAD | 25.5 million CAD |
| 2025 Est. | — | — |
AVCN.TO
Price: CA$0.12
52 week price:
Earnings Per Share: -0.01 CAD
Exchange: TOR
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 18.8 million